Monoacylglycerol lipase (MGL) expressed in cancer cells influences cancer pathogenesis but the role of MGL in the tumor microenvironment (TME) is less known.
M. Kienzl +17 more
semanticscholar +3 more sources
Monoacylglycerol lipase reprograms hepatocytes and macrophages to promote liver regeneration. [PDF]
Background & Aims Liver regeneration is a repair process in which metabolic reprogramming of parenchymal and inflammatory cells plays a major role. Monoacylglycerol lipase (MAGL) is an ubiquitous enzyme at the crossroad between lipid metabolism and ...
Allaire M +15 more
europepmc +2 more sources
A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence. [PDF]
Monoacylglycerol lipase (MAGL) regulates endocannabinoid 2-arachidonoylglycerol (2-AG) and eicosanoid signalling. MAGL inhibition provides therapeutic opportunities but clinical potential is limited by central nervous system (CNS)-mediated side effects ...
Jiang M +28 more
europepmc +2 more sources
Discovery of a non-canonical prototype long-chain monoacylglycerol lipase through a structure-based endogenous reaction intermediate complex. [PDF]
The identification and characterization of enzyme function is largely lacking behind the rapidly increasing availability of large numbers of sequences and associated high-resolution structures.
Pinotsis N +9 more
europepmc +2 more sources
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives. [PDF]
Monoacylglycerol lipase (MAGL) is the enzyme responsible for the metabolism of 2-arachidonoylglycerol in the brain and the hydrolysis of peripheral monoacylglycerols.
Bononi G +19 more
europepmc +2 more sources
Endocannabinoid control of neuroinflammation in traumatic brain injury by monoacylglycerol lipase in astrocytes. [PDF]
Traumatic brain injury (TBI) is a temporary or permanent disruption of brain function caused by external forces. TBI has been recognized as an important risk factor for the development of Alzheimer’s disease and dementia later in life.
Chen C.
europepmc +2 more sources
Novel Aminocyclobutanes as Monoacylglycerol Lipase Modulators. [PDF]
Title. Aminocyclobutanes as Monoacylglycerol Lipase Modulators Patent Publication Number. WO 2021/191391 A1 U R L : h t t p s : / / p a t e n t s . g o o g l e . c o m / p a t e n t / WO2021191391A1/en Publication Date.
Sabnis RW.
europepmc +2 more sources
β-Caryophyllene Inhibits Monoacylglycerol Lipase Activity and Increases 2-Arachidonoyl Glycerol Levels In Vivo: A New Mechanism of Endocannabinoid-Mediated Analgesia? [PDF]
The mechanisms of β-caryophyllene (BCP)-induced analgesia are not well studied. Here, we tested the efficacy of BCP in an acute postsurgical pain model and evaluated its effect on the endocannabinoid system. Rats were treated with vehicle and 10, 25, 50,
Klawitter J +11 more
europepmc +2 more sources
Inhibition of triple negative breast cancer-associated inflammation, tumor growth and brain colonization by targeting monoacylglycerol lipase. [PDF]
While the prevalence of breast cancer metastasis in the brain is significantly higher in triple negative breast cancers (TNBCs), there is a lack of novel and/or improved therapies for these patients. Monoacylglycerol lipase (MAGL) is a hydrolase involved
Benchama O +5 more
europepmc +2 more sources
Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases. [PDF]
Neurological and neurodegenerative diseases are debilitating conditions, and frequently lack an effective treatment. Monoacylglycerol lipase (MAGL) is a key enzyme involved in the metabolism of 2-AG (2-arachidonoylglycerol), a neuroprotective ...
Zanfirescu A +4 more
europepmc +2 more sources

